News by Subject Medicine & Health

Peptide receptor radionuclide therapy (PRRT) has been shown to be safe and effective for patients with grade 3 (G3) neuroendocrine neoplasms (NENs), according to research presented at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 66th Annual Meeting.

A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting.

Researchers develop molecular testing to distinguish patients who may need less from those who may need more therapy for HER2 positive breast cancer.

To better understand the cells that brain tumors recruit, scientists developed advanced imaging techniques to visualize macrophages.

A team of researchers from Jena presents a groundbreaking new method for the rapid, gentle and reliable detection of tumors with laser light. The Leibniz Institute of Photonic Technology (Leibniz IPHT) introduced a compact device for rapid cancer diagnosis during surgery at the leading trade fair "Laser World of Photonics" from 24 to 27 June 2019 in Munich. The optical method will help surgeons to remove tumors more precisely and perspectively could make cancer operations possible without a scalpel.